|
Doc Drug Purchase Debacle Prompts FDA Call for More Supply Chain Authority
Additional FDA authority and improved notification of suspected counterfeits could help the agency strengthen pharma supply chain integrity and keep unapproved and counterfeit products from reaching U.S. physicians, it says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives